AR066791A1 - ARTICLES FOR SMOKING AND METHOD FOR INCORPORATING SALTS OF LANTANID METALS TO REDUCE TPM CYTO TOXICITY AND SPECIFIC CONSTITUENTS IN TOBACCO SMOKE - Google Patents

ARTICLES FOR SMOKING AND METHOD FOR INCORPORATING SALTS OF LANTANID METALS TO REDUCE TPM CYTO TOXICITY AND SPECIFIC CONSTITUENTS IN TOBACCO SMOKE

Info

Publication number
AR066791A1
AR066791A1 ARP080102295A ARP080102295A AR066791A1 AR 066791 A1 AR066791 A1 AR 066791A1 AR P080102295 A ARP080102295 A AR P080102295A AR P080102295 A ARP080102295 A AR P080102295A AR 066791 A1 AR066791 A1 AR 066791A1
Authority
AR
Argentina
Prior art keywords
smoking
tpm
lantanid
articles
metals
Prior art date
Application number
ARP080102295A
Other languages
Spanish (es)
Original Assignee
Philip Morris Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philip Morris Prod filed Critical Philip Morris Prod
Publication of AR066791A1 publication Critical patent/AR066791A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/287—Treatment of tobacco products or tobacco substitutes by chemical substances by inorganic substances only
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/42—Treatment of tobacco products or tobacco substitutes by chemical substances by organic and inorganic substances

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cigarettes, Filters, And Manufacturing Of Filters (AREA)

Abstract

Se provee un artículo para fumar y un método para reducir la citotoxicidad TPM y los constituyentes específicos en el humo directo. El artículo para fumar (10) incluye material de tabaco (12) que incluye una sal de un metal lantánido (14). El método incluye combinar una sal de un metal lantánido (14), agua, y opcionalmente glicerina para producir una solucion que es aplicada al material de tabaco (12). Preferentemente, la sal es un acetato, un sulfato o un gluconato.An article for smoking and a method for reducing the cytotoxicity TPM and the specific constituents in direct smoke are provided. The smoking article (10) includes tobacco material (12) that includes a salt of a lanthanide metal (14). The method includes combining a salt of a lanthanide metal (14), water, and optionally glycerin to produce a solution that is applied to the tobacco material (12). Preferably, the salt is an acetate, a sulfate or a gluconate.

ARP080102295A 2007-05-31 2008-05-30 ARTICLES FOR SMOKING AND METHOD FOR INCORPORATING SALTS OF LANTANID METALS TO REDUCE TPM CYTO TOXICITY AND SPECIFIC CONSTITUENTS IN TOBACCO SMOKE AR066791A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92479607P 2007-05-31 2007-05-31

Publications (1)

Publication Number Publication Date
AR066791A1 true AR066791A1 (en) 2009-09-09

Family

ID=40075608

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080102295A AR066791A1 (en) 2007-05-31 2008-05-30 ARTICLES FOR SMOKING AND METHOD FOR INCORPORATING SALTS OF LANTANID METALS TO REDUCE TPM CYTO TOXICITY AND SPECIFIC CONSTITUENTS IN TOBACCO SMOKE

Country Status (4)

Country Link
US (1) US20090000631A1 (en)
AR (1) AR066791A1 (en)
TW (1) TW200904344A (en)
WO (1) WO2008146173A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201032738A (en) * 2009-01-23 2010-09-16 Japan Tobacco Inc Cigarette

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE640193C (en) * 1933-03-24 1936-12-24 Karl Klein Dr Ing Process for reducing the nicotine content in tobacco smoke
US3039475A (en) * 1958-04-11 1962-06-19 Sasmoco Sa Tobacco process, and product
US3474792A (en) * 1966-08-05 1969-10-28 Eastman Kodak Co Treatment of smoking tobacco with chlorate salts
US4055191A (en) * 1974-04-05 1977-10-25 Liggett & Myers Incorporated Tobacco composition
US4216784A (en) * 1977-10-03 1980-08-12 Liggett Group Inc. Tobacco composition
US4248251A (en) * 1979-02-21 1981-02-03 Liggett Group Inc. Tobacco composition
US4236533A (en) * 1979-04-13 1980-12-02 Tkr Tabak Forschnugs-Gmbh & Co. Novel cigarette process and product produced therefrom
US5132264A (en) * 1991-07-01 1992-07-21 Heiko Mauermann Concentrated water soluble organic lanthanide salts
AU9156701A (en) * 2000-09-18 2002-04-02 Rothmans Benson Low sidestream smoke cigarette with combustible paper
EP1408780A2 (en) * 2000-11-10 2004-04-21 Vector Tobacco Ltd. Method and product for removing carcinogens from tobacco smoke
CN100496743C (en) * 2001-09-14 2009-06-10 乐富门.本森及赫奇斯有限公司 Process for making metal oxide-coated microporous materials
CA2538645A1 (en) * 2003-09-15 2005-03-24 Rothmans, Benson & Hedges Inc. Treatment of mainstream smoke constituents by use of oxygen storage and donor metal oxide oxidation catalyst
CN1218669C (en) * 2003-09-17 2005-09-14 费德厚 Toxin-reducing dehabit preparation of cigarette with health-care function
US20060086367A1 (en) * 2004-10-25 2006-04-27 Philip Morris Usa Inc. Additives for tobacco cut filler
US20060225753A1 (en) * 2005-02-22 2006-10-12 Rothmans, Benson & Hedges, Inc. Tobacco smoke filter and tobacco blend for altering mainstream smoke
WO2007012980A1 (en) * 2005-06-01 2007-02-01 Philip Morris Products S.A. Tobacco with an increased level of natural tar dilutents

Also Published As

Publication number Publication date
WO2008146173A2 (en) 2008-12-04
WO2008146173A3 (en) 2009-08-13
TW200904344A (en) 2009-02-01
WO2008146173A8 (en) 2009-02-26
US20090000631A1 (en) 2009-01-01

Similar Documents

Publication Publication Date Title
AR072261A1 (en) PIPERAZIN-PIRAZOLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEMSELVES AND USES OF THE SAME AS ANTICANCERIGEN AGENTS.
BRPI0516798A (en) cosmetic method of inhibiting or preventing skin darkening, cosmetic composition and cosmetic method of simultaneously inhibiting sweat and inhibiting skin darkening
PE20080180A1 (en) ORAL PREPARATION OF PIOGLITAZONE
CR9857A (en) IRON SUPPLEMENT COMPOSITIONS WITH IMPROVED TOLERANCE
CL2015001694A1 (en) Composition comprising a tetrabasic-amino acid or trialkyl glycine and cysteine zinc halide complex in free form or orally or cosmetically acceptable salt; and its use to eliminate bacteria, reduce perspiration and / or body odor, treat or reduce acne, clean teeth and inhibit tooth decay, among others.
MX365138B (en) Prolyl hydroxylase inhibitors.
CY1112021T1 (en) PROLYL HYDROXOLOGY INHIBITIONS AND METHODS OF USE
CO6650415A2 (en) New dosage forms of modified release of an xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
AR055076A1 (en) 1,1-DIOXIDE DERIVATIVES OF 1,4-BENZOTIAZEPIN, PROCEDURE TO PREPARE THEM, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES IN THERAPEUTICS.
CR8903A (en) METHOD FOR THE PROTECTION OF USEFUL PLANTS OR PLANT PROPAGATION MATERIAL
LU92484I2 (en) Paclitaxel formulated as albumin bound to nanoparticles
MA35749B1 (en) Nucleoside derivatives 4'-azido, 3'-fluoro substituted as inhibitors of vhc arn replication
AR056055A1 (en) CRYSTALLINE AND HYDRATIC COMPLEXES OF 1-CHLORINE-4- (BETA-D-GLUCOPIRANOS-1-IL) -2- (4-ETINIL-BENCIL) -BENZENE
AR073603A1 (en) SYNERGIC COMBINATIONS OF A HCV MACROCICLIC INHIBITOR AND A NUCLEOSIDE
ES2547852T3 (en) Use of biotin or a biotin derivative for skin lightening and / or for smoothing colored skin irregularities
GT201200181A (en) CRYSTAL FORMS OF 3- (2,6-DICLORO-3,5-DIMETOXI-PHENYL) -1- {6- [4- (4-ETIL-PIPERAZIN-1-IL} -PENYL-AMINO] -PIRIMIDIN-4- IL] -1-METHYL-UREA AND SALTS OF THE SAME
AR054448A1 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ARSENIOUS ACID, ITS SODIUM SALT AND ITS DERIVATIVES INTENDED FOR THE TREATMENT OF UROGENITAL CANCER AND ITS METASTASIS
PE20120476A1 (en) STABILIZED PHARMACEUTICAL COMPOSITIONS INCLUDING FESOTERODINE
AR074541A1 (en) NATURAL SILVER DISINFECTANT COMPOSITIONS
CL2008001118A1 (en) COMPOSITION OF GRANULAR WATER TREATMENT THAT INCLUDES 35 TO 95% IN CALCIUM HYPOCLORITE WEIGHT, 1 to 50% MAGNESIUM SULFATE, 0.1 to 10% CAL AND 0.1 to 55% ZINC SALT WATER SOLUBLE ; COMPRESSED FOR WATER TREATMENT; AND METHOD FOR
SV2010003770A (en) COMPOSITION AND PROCESS- 356
AR076263A1 (en) COMPOSITIONS AND METHODS TO TREAT CANCER. USE.
PE20141035A1 (en) COMPOSITIONS AND METHODS FOR TREATING CANCER USING THE PI3KBETA INHIBITOR AND THE MAPK VIA INHIBITOR, INCLUDING MEK AND RAF INHIBITORS
AR066791A1 (en) ARTICLES FOR SMOKING AND METHOD FOR INCORPORATING SALTS OF LANTANID METALS TO REDUCE TPM CYTO TOXICITY AND SPECIFIC CONSTITUENTS IN TOBACCO SMOKE
AR055939A1 (en) METHODS TO PREPARE PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ACETATO DE ESLICARBAZEPINA AND METHODS OF USE

Legal Events

Date Code Title Description
FB Suspension of granting procedure